ABBVAbbVie Inc.
EMA-Trend
RSI (14)
64.1
52W
+40.6%
Volatility
33.7%
Last updated: July 24, 2026 at 03:24 AM
Technical analysis for AbbVie Inc. stock (ABBV), trend direction, momentum strength and risk metrics based on 16 quantitative signals, updated daily.
Signal Overview
16 quantitative indicators, updated daily
The signal score is a weighted average across the signals, not a simple majority vote. Some areas, like trend or the macro environment, can carry more weight than others and offset a mixed picture among the individual signals.
Trend
Momentum
Oscillators
Macro & Relative
Signal Analysis in Detail
EMA Crossover, Trend Direction
FAVORABLECompares a fast moving average to a slow one. When the fast is above the slow, the trend is positive. Period settings are automatically calibrated per asset class.
For AbbVie Inc., the fast moving average is currently above the slow one. By this indicator's definition that corresponds to an uptrend, a description of past price action.
ADX, Trend Strength Filter
34.6ADX does not measure direction, only how pronounced a trend is, regardless of whether it points up or down. We use it as a filter: only above a certain value does a trend count as strong enough to give other signals more weight. Direction itself comes from the separate ADX Direction signal.
ADX stands at 34.6, a pronounced trend, regardless of its direction.
RSI, Momentum Strength
64.1The Relative Strength Index measures the ratio of upward to downward price movements over the last 14 trading days (Wilder smoothing) on a scale of 0 to 100. Our neutral zone is 45 to 55, tighter than the classic 30/70 band, outside of it the methodology reads the RSI as overbought or oversold.
RSI stands at 64.1, in the zone this indicator defines as overbought, upward moves clearly outweighed downward moves in recent days. Historically, a high RSI occurred both before consolidations and within longer phases of strength.
MACD, Trend Momentum
-0.2%MACD measures the gap between two exponentially smoothed averages. Our periods are 12/20/9 instead of the common 12/26/9, and the signal threshold is normalized to 0.3% of the current price rather than the raw MACD value, which keeps the threshold comparable across different price levels.
MACD stands at -0.2%, within the neutral zone around the threshold, no clear momentum in either direction.
Rate of Change, Price Change Over 63 Trading Days
+28.1%Rate of Change measures the percentage price change over the last 63 trading days, roughly one quarter, a medium-term window, not a short-term daily or weekly read.
AbbVie Inc. is +28.1% higher than 63 trading days ago, a positive medium-term price change.
52-Week High, Distance from Yearly High
98.4%Measures how close the current price is to its highest point over the last 252 trading days, roughly one year. A value near 100% means the price is at or near its yearly high.
AbbVie Inc. trades at 98.4% of its 52-week high, near the highest point of the last 252 trading days.
Momentum Oscillator, Speed of Price Movement
+2.7%Checks whether the recent price movement is accelerating or decelerating. Unlike Rate of Change, this indicator measures the pace of the change, not the change itself.
AbbVie Inc. shows an accelerating upward move at +2.7%, recent price gains are larger than before.
Williams %R, Position in Trading Range
-22.4Williams %R shows where the current price sits within the high-low range of the last 14 trading days. We read it as contrarian: a favorable signal only fires on a confirmed turn upward out of the oversold zone, not on any low value by itself, an extreme oversold reading alone never produces a cautious signal for us.
Williams %R stands at -22.4, a neutral position. The price is in the middle of the recent trading range, without extremes in either direction.
Stochastic %K, Confirmed Reversal Crossover
77.6The Stochastic oscillator shows where the closing price sits within the recent trading range. A low or high value alone isn't enough for us: a signal only fires once %K and %D are both below 20 (or above 80) and %K is crossing upward (or downward), a confirmed turning point rather than a raw level.
Stochastic %K stands at 77.6, currently without a confirmed crossover in either direction.
Relative Strength, Performance vs Reference Index
1.20Compares price performance over a medium-term period against a broad stock market index as a reference. A value above 1.0 means stronger performance than the reference index, below 1.0 means weaker.
AbbVie Inc. stands at 1.20, above the reference index, price performance over the period was stronger than the reference index's.
Technical Assessment
Trend
5 of 5 trend signals read positive. ADX at 34.6 indicates a pronounced trend. The price is above the 200-day moving average.
Momentum
4 of 5 momentum signals read positive. RSI at 64.1 is in the overbought zone.
Risk Metrics
30-day volatility at 33.7%. price at or near its 52-week high. Sharpe Ratio at 1.41 indicates a good risk-adjusted return over 12 months.
Market Environment
VIX at 18.7 indicates normal expected market volatility. The high-yield spread signal reads positive.
Sector Context
52-week return of 40.6% is below the Healthcare sector average of 42.8%. Ranked #2 of 20 Healthcare titles by signal score.
Performance
1 day
+1.4%
4 weeks
+9.4%
52 weeks
+40.6%
Risk Metrics
Volatility (30d)
33.7%
Annualized price fluctuation over the last 30 trading days. Higher values mean larger price swings.
Max Drawdown (52w)
-17.3%
Largest decline from peak over the last 52 weeks, the worst-case scenario that actually occurred.
Current Drawdown
-1.6%
How far is the current price below its 52-week high? 0% means at or near the peak.
Sharpe Ratio (1y)
1.41
Return relative to risk taken over 1 year. Values above 1.0 are considered good, above 2.0 excellent.
More Healthcare titles
#2 of 20 Healthcare titles by signal scoreMerck & Co., Inc.
Johnson & Johnson
UnitedHealth Group Incorporated
Eli Lilly and Company
Fresenius Medical Care AG
Roche Holding AG
Methodology & Background
How the signals are calculated and what they measure
8 Min.
RSI Aktien: Was der Relative-Strength-Index misst, was er nicht misst und warum die Standardschwellen oft falsch eingesetzt werden
8 Min.
EMA Crossover erklärt: Wie das Signal funktioniert und welche Perioden Tests bestanden haben
9 Min.
16 Signale, 148 Aktien, 12 Jahre: Was unsere Backtests wirklich zeigen
The information presented does not constitute investment advice and should not be construed as a solicitation to buy or sell financial instruments. Past performance is not a reliable indicator of future results. Any investment decision should be based on your own research and, where appropriate, professional advice. Marvin Waraschitz, founder of edgio, currently holds no position in ABBV. Methodology & full disclaimer: disclaimer.
Analyze ABBV in your own portfolio
Score breakdown, backtest comparison, and signal history for ABBV are available in your own portfolio in edgio.
- Score breakdown: which signals drive the score
- 3 backtested strategies compared for ABBV
- Correlation with your other positions
- Risk budget impact
- Signal changes via email
- Create your own strategies with the backtest engine
Your portfolio, 16 signals, one score.
Import your portfolio and see where you stand, with daily signal updates, risk metrics, and a clear read on each position.
Join the waitlist